$3.76
0.143.87%
At close: -
$3.76
0.000.00%
After Hours: 6:02 PM EDT
Comments
Loading...
Perspective Therapeutics Earnings Estimates, EPS & Revenue | AMEX:CATX | Benzinga
Perspective Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 11
EPS Estimate
$-0.290
Quarterly Revenue Estimate
$185.86K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Perspective Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CATX | Perspective Therapeutics | -$0.17 | -$0.29 | — | — | $526.00K | $185.86K | — | — | 08/11/2025 | Get Alert |
| CATX | Perspective Therapeutics | -$0.24 | -$0.27 | -$0.25 | 7.41% | $325.00K | $143.93K | $342.00K | 137.62% | 05/12/2025 | Get Alert |
| CATX | Perspective Therapeutics | -$0.90 | -$0.26 | -$0.60 | -130.77% | $2.03M | $302.51K | $234.00K | -22.65% | 03/26/2025 | Get Alert |
| CATX | Perspective Therapeutics | -$0.34 | -$0.21 | -$0.21 | 0.00% | $276.00K | $170.00K | $369.00K | 117.06% | 11/12/2024 | Get Alert |
| CATX | Perspective Therapeutics | -$0.34 | -$0.21 | -$0.17 | 19.05% | $588.00K | $60.00K | $526.00K | 776.67% | 08/12/2024 | Get Alert |
| CATX | Perspective Therapeutics | $0.00 | -$0.20 | -$0.20 | 0.00% | $233.00K | — | $325.00K | — | 05/15/2024 | Get Alert |
| CATX | Perspective Therapeutics | -$0.01 | — | -$0.90 | — | $2.50M | — | $2.03M | — | 03/28/2024 | Get Alert |
| CATX | Perspective Therapeutics | -$0.03 | -$0.40 | -$0.40 | 0.00% | $1.72M | $2.22M | $2.19M | -1.58% | 11/14/2023 | Get Alert |
| CATX | Perspective Therapeutics | -$0.01 | -$0.30 | -$0.40 | -33.33% | $2.82M | $2.61M | $2.09M | -20.00% | 08/11/2023 | Get Alert |
| CATX | Perspective Therapeutics | -$0.02 | -$0.10 | $0.00 | 100.00% | $2.56M | $4.30M | $2.06M | -52.02% | 05/15/2023 | Get Alert |
| CATX | Perspective Therapeutics | -$0.01 | -$0.01 | -$0.02 | -100.00% | $2.82M | $4.20M | $1.83M | -56.31% | 02/16/2023 | Get Alert |
| CATX | Perspective Therapeutics | -$0.01 | -$0.01 | -$0.01 | 0.00% | $2.71M | $2.84M | $2.50M | -11.80% | 09/28/2022 | Get Alert |
| CATX | Perspective Therapeutics | -$0.01 | — | -$0.01 | — | $2.60M | $3.11M | $2.91M | -6.43% | 05/10/2022 | Get Alert |
| CATX | Perspective Therapeutics | -$0.01 | -$0.01 | -$0.01 | 0.00% | $2.36M | $2.95M | $2.82M | -4.54% | 02/08/2022 | Get Alert |
| CATX | Perspective Therapeutics | -$0.01 | -$0.01 | -$0.02 | -100.00% | $2.38M | $2.49M | $2.56M | 2.97% | 11/10/2021 | Get Alert |
| CATX | Perspective Therapeutics | -$0.02 | -$0.01 | -$0.01 | 0.00% | $2.28M | $2.75M | $2.71M | -1.45% | 09/21/2021 | Get Alert |
| CATX | Perspective Therapeutics | -$0.01 | -$0.01 | -$0.01 | 0.00% | $2.88M | $2.43M | $2.60M | 7.00% | 05/13/2021 | Get Alert |
| CATX | Perspective Therapeutics | -$0.01 | -$0.01 | -$0.01 | 0.00% | $2.21M | $2.39M | $2.36M | -1.30% | 02/09/2021 | Get Alert |
| CATX | Perspective Therapeutics | -$0.01 | -$0.01 | -$0.01 | 0.00% | $2.31M | $2.85M | $2.38M | -16.35% | 11/10/2020 | Get Alert |
| CATX | Perspective Therapeutics | -$0.02 | -$0.01 | -$0.02 | -100.00% | $1.92M | $2.70M | $2.28M | -15.59% | 09/17/2020 | Get Alert |
Perspective Therapeutics (CATX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-12 | $-0.25 | $-0.27 | 7.41 % |
| Q4 | 2025-03-26 | $-0.60 | $-0.26 | -130.8 % |
| Q3 | 2024-11-12 | $-0.21 | $-0.21 | 0.00 % |
| Q2 | 2024-08-12 | $-0.17 | $-0.21 | 19.1 % |
Perspective Therapeutics (CATX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-12 | $342.00K | $143.93K | 137.6 % |
| Q4 | 2025-03-26 | $234.00K | $302.51K | -22.7 % |
| Q3 | 2024-11-12 | $369.00K | $170.00K | 117.1 % |
| Q2 | 2024-08-12 | $526.00K | $60.00K | 776.7 % |
FAQ
When is Perspective Therapeutics (AMEX:CATX) reporting earnings?
Perspective Therapeutics (CATX) is scheduled to report earnings on August 11, 2025. The last reported earnings were for reported on May 12, 2025 for Q1.
What were the latest earnings per share (EPS) for Perspective Therapeutics (AMEX:CATX)?
The Actual EPS was $-0.25, which beat the estimate of $-0.27.
What were Perspective Therapeutics’s (AMEX:CATX) revenues?
The Actual Revenue was $342K, which beat the estimate of $143.9K.
Browse earnings estimates, EPS, and revenue on all stocks.
